| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446982 | European Journal of Cancer | 2011 | 7 Pages |
Abstract
The combination of NPLD and docetaxel demonstrated high antitumour activity in a population of metastatic breast cancer patients exposed to adjuvant anthracyclines and showed an unexpected and unexplained 15% symptomatic left ventricular systolic dysfunction rate.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
E. Curtit, P. Nouyrigat, N. Dohollou, E. Levy, A. Lortholary, J. Gligorov, T. Facchini, D. Jaubert, N. Maille, X. Pivot, V. Grangé, L. Cals,